Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

被引：0
|
作者：
Makoto Sudo
Tan Min Chin
Seiichi Mori
Ngan B. Doan
Jonathan W. Said
Makoto Akashi
H. Phillip Koeffler
机构：
[1] National University of Singapore,Cancer Science Institute
[2] National University Hospital,Department of Hematology and Oncology
[3] The Cancer Institute,Department of Cancer Genomics
[4] Japanese Foundation for Cancer Research,Department of Pathology and Laboratory Medicine
[5] University of California,Research Center for Radiation Emergency
[6] National Institute of Radiological Sciences,Division of Hematology and Oncology
[7] Cedars-Sinai Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Non-small cell lung cancer (NSCLC); Tyrosine kinase inhibitor (TKI); EGFR; 17-DMAG; Belinostat; Combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1325 / 1334
页数：9
相关论文
共 50 条
  • [31] Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells
    Chiu, Huan-Chih
    Chou, Ding-Li
    Huang, Chin-Ting
    Lin, Wen-Hsing
    Lien, Tzu-Wen
    Yen, Kuei-Jung
    Hsu, John T. -A.
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (11) : 1263 - 1270
  • [32] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [33] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [34] Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro
    Hu, Yong
    Zang, Jialan
    Cao, Haixia
    Wu, Ying
    Yan, Dali
    Qin, Xiaobing
    Zhou, Leilei
    Fan, Fan
    Ni, Jie
    Xu, Xiaoyue
    Sha, Huanhuan
    Liu, Siwen
    Yu, Shaorong
    Wang, Zhuo
    Ma, Rong
    Wu, Jianzhong
    Feng, Jifeng
    ONCOTARGET, 2017, 8 (09) : 15802 - 15814
  • [35] Suppression of Stat3 Activity Sensitizes Gefitinib-resistant Non Small Cell Lung Cancer Cells
    Hsu, J.
    Chiu, H.
    Chou, D.
    Huang, C.
    Lin, W.
    Lien, T.
    Yen, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S104 - S104
  • [36] RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancer
    Kaneto, Naoki
    Yokoyama, Satoru
    Hayakawa, Yoshihiro
    Kato, Shinichiro
    Sakurai, Hiroaki
    Saiki, Ikuo
    CANCER SCIENCE, 2014, 105 (07) : 788 - 794
  • [37] Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
    La Monica, Silvia
    Galetti, Maricla
    Alfieri, Roberta R.
    Cavazzoni, Andrea
    Ardizzoni, Andrea
    Tiseo, Marcello
    Capelletti, Marzia
    Goldoni, Matteo
    Tagliaferri, Sara
    Mutti, Antonio
    Fumarola, Claudia
    Bonelli, Mara
    Generali, Daniele
    Petronini, Pier Giorgio
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (05) : 460 - 468
  • [38] Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
    Tang, Mei-Chuan
    Wu, Mei-Yi
    Hwang, Ming-Hung
    Chang, Ya-Ting
    Huang, Hui-Ju
    Lin, Anya Maan-Yuh
    Yang, James Chih-Hsin
    PLOS ONE, 2015, 10 (03):
  • [39] Anticancer Effects of Paris Saponins by Apoptosis and PI3K/AKT Pathway in Gefitinib-Resistant Non-Small Cell Lung Cancer
    Zhu, Xinhai
    Jiang, Hao
    Li, Jinhui
    Xu, Ji
    Fei, Zhenghua
    MEDICAL SCIENCE MONITOR, 2016, 22 : 1435 - 1441
  • [40] Picropodophyllotoxin Inhibits Cell Growth and Induces Apoptosis in Gefitinib-Resistant Non-Small Lung Cancer Cells by Dual-Targeting EGFR and MET
    Lee, Jin-Young
    Kang, Bok Yun
    Jung, Sang-Jin
    Kwak, Ah-Won
    Lee, Seung-On
    Park, Jin Woo
    Joo, Sang Hoon
    Yoon, Goo
    Lee, Mee-Hyun
    Shim, Jung-Hyun
    BIOMOLECULES & THERAPEUTICS, 2023, 31 (02) : 200 - 209
12345